Show simple item record

dc.contributor.authorBulur, H
dc.contributor.authorOzturk, S
dc.contributor.authorOrhan, L
dc.contributor.authorGulbaran, M
dc.contributor.authorErsanli, M
dc.contributor.authorBabalik, E
dc.contributor.authorGurmen, T
dc.date.accessioned2021-03-04T12:35:17Z
dc.date.available2021-03-04T12:35:17Z
dc.date.issued2003
dc.identifier.citationBabalik E., Gurmen T., Orhan L., Bulur H., Gulbaran M., Ersanli M., Ozturk S., "Increased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients", CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, cilt.58, sa.3, ss.306-312, 2003
dc.identifier.issn1522-1946
dc.identifier.otherav_78079ac2-a4ae-4b8e-9807-c63523e7ffe2
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/82363
dc.identifier.urihttps://doi.org/10.1002/ccd.10409
dc.description.abstractInsulin is known to stimulate proliferation and migration of vascular smooth muscle cells. As the predominant mechanism of restenosis after stent implantation is neointimal tissue proliferation, one can expect a relationship between hyperinsulinemia and restenosis in these patients. The aim of this study was to determine whether hyperinsulinemia during oral glucose tolerance test is a predictor of the development of restenosis after stent implantation in nondiabetic patients. We prospectively studied 52 nondiabetic patients with effort angina who underwent elective stent implantation for single-vessel coronary artery disease. In order to increase the statistical power of the study, numerous exclusion criteria were applied. All patients were subjected to a 75 g oral glucose tolerance test a day before the stent implantation and underwent follow-up angiography 6 months later. Plasma insulin levels in fasting (6.77 +/- 1.57 vs. 5.36 +/- 1.35 muU/ml; P = 0.005), at 30 min (102.48 +/- 10.6 vs. 47.74 +/- 12.75 muU/ml; P = 0.001), 1 hr after (120.23 +/- 14.1 vs. 63.08 +/- 12.62 mu/ml; P = 0.001), 2 hr after (63.58 +/- 8.64 vs. 34.88 +/- 6.82 mu/ml; P = 0.001), and 3 hr after (25.71 +/- 5.65 vs. 23.02 +/- 4.61 mu/ml; P = 0.04) loading were significantly higher in patients with stent restenosis than in patients without stent restenosis. Insulin area and insulin area/glucose area were also significantly higher in patients with stent restenosis than in patients without (219.5 +/- 23.8 vs. 118.9 +/- 21.8, P = 0.001, and 0.62 +/- 0.09 vs. 0.33 +/- 0.06, P = 0.001, respectively). By multiple logistic regression analysis, insulin area during oral glucose tolerance test was found to be an independent predictor of stent restenosis (OR = 1.12; 95% CI = 1.01-1.25; P = 0.031). In conclusion, nondiabetic patients with hyperinsulinemia during oral glucose tolerance test have a high risk for restenosis after stent implantation, and performing this simple test before intervention may be useful for the prediction of stent restenosis.
dc.language.isoeng
dc.subjectKardiyoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.titleIncreased secretion of insulin during oral glucose tolerance test can be a predictor of stent restenosis in nondiabetic patients
dc.typeMakale
dc.relation.journalCATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS
dc.contributor.department, ,
dc.identifier.volume58
dc.identifier.issue3
dc.identifier.startpage306
dc.identifier.endpage312
dc.contributor.firstauthorID167769


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record